Free shipping on all orders over $ 500

TM6008

Cat. No. M8979
TM6008 Structure
Size Price Availability
5mg USD 550  USD550 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TM6008 is a prolyl hydroxylase (PHD) inhibitor that protects against cell death after hypoxia. TM6008 suppresses the activity of PHDs, inducing continuous HIF-1α activation. Immunoblotting revealed that TM6008 increased the expression of HIF-1α, HIF-2α and vascular endothelial growth factor in myocarditis.

In vivo, TM6008 improved left ventricular ejection fraction significantly on the 21st day of EAM. Though TM6008 did not affect the severity of myocardial cell infiltration, it tended to reduce cardiac fibrosis. Immunohistochemistry showed that CD31-positive blood vessels were preserved in the TM6008 group compared to the control group. Immunoblotting revealed that TM6008 increased the expression of HIF-1α, HIF-2α and vascular endothelial growth factor in myocarditis. Oral administration of TM6008 protected neurons in a model of cerebrovascular disease.

Chemical Information
Molecular Weight 387.39
Formula C21H17N5O3
CAS Number 945008-17-3
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Tada Y, et al. Expert Opin Investig Drugs. Neovascularization induced by hypoxia inducible transcription factor is associated with the improvement of cardiac dysfunction in experimental autoimmune myocarditis.

[2] Kontani S, et al. Neurochem Res. A novel prolyl hydroxylase inhibitor protects against cell death after hypoxia.

[3] Takizawa S, et al. Rinsho Shinkeigaku. [Novel neuroprotective agents: a HIF activator and an Akt activator].

[4] Takeda K, et al. Arterioscler Thromb Vasc Biol. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.

[5] Nangaku M, et al. Arterioscler Thromb Vasc Biol. A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia.

Related HIF Products
3-Aminobenzoic acid

3-Aminobenzoic acid is a hypoxia-inducible factor-1α (HIF-1α) inhibitor.

Steppogenin

Steppogenin is a potent inhibitor of HIF-1α and DLL4, with IC50 values of 0.56 and 8.46 μM, respectively.

HIV-IN-7

Axl-IN-16 is a Axl inhibitor.

HIF-2α-IN-9

HIF-2α-IN-9 is an inhibitor ofHIF-2α.

PHD-IN-2

PHD-IN-2 is a PHD antagonist (IC50: < 5 nM).

  Catalog
Abmole Inhibitor Catalog




Keywords: TM6008 supplier, HIF, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.